EntryPoint Capital’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-862	Closed	-$43.3K	–	1342
2024 Q1	$43.3K	Sell	862 -860	-50%	-$43.2K	0.04%	829
2023 Q4	$104K	Buy	+1,722	New	+$104K	0.1%	365